Could your patients benefit from a completely preservative-free glaucoma medication?
Adherence
A major cause of intolerance or poor tolerance to glaucoma medication is the ocular surface changes created by treatment.1 Since glaucoma treatments are used long-term, for treatment to be effective, patient adherence is vital2—one way to improve patient adherence is to minimize side effects associated with treatment.
Preservative-free Benefits
Commonly used preservatives in glaucoma medicines, such as BAK (benzalkonium chloride), have demonstrated adverse ocular effects.3 Long-term use of preservative-containing medication may induce changes in the ocular surface and damage conjunctival and corneal epithelial cells.4
Preservative-free eye drops may have a significant medical advantage.5
By minimizing or not causing the serious adverse effects associated with preserved eye drops, they allow patients to remain compliant with their daily medication.
The availability of a preservative-free medication like TIMOPTIC® in OCUDOSE® offers a better alternative for your patients who are sensitive to glaucoma medication preservative side effects.
- Preservative-free Sterile Ophthalmic Solution TIMOPTIC® is supplied in OCUDOSE®, a clear, individual, unit dose container6
Click any of the links above for more information about the benefits of preservative-free glaucoma medication and get your patients started on TIMOPTIC® in OCUDOSE® today.
TIMOPTIC® in OCUDOSE® is indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
References: 1. Detry-Morel M. Side effects of glaucoma medications. Bull Soc Delge Ophtalmol. 2006;27-40. 2. Nordmann JP, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health and Quality of Life Outcomes. 2003;1:75. doi:10.1186/1477-7525-1-75. 3. Kahook MY, Noecker RJ. Dosing of Travoprost preserved with sofZia, Latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Cornea. 2008;27:339-343. 4. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490-496. 5. Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol. 2002;86:418-423. 6. Timoptic (timolol maleate ophthalmic solution) in Ocudose (dispenser) [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2009.
